Darunavir
| CAS No. | 206361-99-1 |
|---|---|
| MDL No. | MFCD09260006 |
| MF | C27H37N3O7S |
| MW | 547.70 |
| InChI Key | CJBJHOAVZSMMDJ-HEXNFIEUSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Darunavir is an N,N-disubstituted benzenesulfonamide with an unsubstituted amino group at the 4-position, used in the treatment of HIV infection. As a second-generation HIV protease inhibitor, it is designed to form strong interactions with the protease enzyme from various HIV strains, including those from treatment-experienced patients with multiple resistance mutations. It functions as a HIV protease inhibitor and antiviral drug, and is classified as a furofuran, carbamate ester, and sulfonamide.
| CAS No. | 206361-99-1 |
|---|---|
| Product Name | Darunavir |
Associated Conditions
hepatitis C virus infection·HIV-1 infection·viral disease·COVID-19·Insulin resistance·
* The information provided here is compiled from public sources and is for reference only.
